Etorphines: mu-opioid receptor-selective antinociception and low physical dependence capacity.

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Pharmacology

• Publication date

  1997-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0014-2999(97)81924-3PMID 9424015
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Etorphine elicits anomalous excitatory opioid effects on sensory neurons treated with GM1 ganglioside or pertussis toxin in contrast to its potent inhibitory effects on naive or chronic morphine-treated cells.

  1996cited by this paper
• The biological, social and clinical bases of drug addiction: commentary and debate

  1996cited by this paper
• Loss of morphine-induced analgesia, reward effect and withdrawal symptoms in mice lacking the µ-opioid-receptor gene

  1996cited by this paper
• Dual regulation by μ, δ and κ opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma × DRG neuron hybrid F11 cells

  1995cited by this paper
• Dihydroetorphine is a μ‐Receptor‐selective Ligand

  1995cited by this paper
• Dual regulation by mu, delta and kappa opioid receptor agonists of K+ conductance of DRG neurons and neuroblastoma X DRG neuron hybrid F11 cells.

  1995cited by this paper
• Opioid receptor interaction and adenylyl cyclase inhibition of dihydroetorphine: direct comparison with etorphine.

  1995cited by this paper
• Specific N- or C-terminus modified dynorphin and beta-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists.

  1995cited by this paper
• Ultra-low concentrations of naloxone selectively antagonize excitatory effects of morphine on sensory neurons, thereby increasing its antinociceptive potency and attenuating tolerance/dependence during chronic cotreatment.

  1995cited by this paper
• Etorphine elicits unique inhibitory-agonist and excitatory-antagonist actions at opioid receptors on sensory neurons: new rationale for improved clinical analgesia and treatment of opiate addiction.

  1995cited by this paper
• Dihydroetorphine is a mu-receptor-selective ligand.

  1995cited by this paper
• Antinociceptive effect of dihydroetorphine in diabetic mice.

  1995cited by this paper
• Specific N- or C-terminus modified dynorphin and β-endorphin peptides can selectively block excitatory opioid receptor functions in sensory neurons and unmask potent inhibitory effects of opioid agonists

  1995cited by this paper
• Dihydroetorphine, a potent opioid with low dependent potential

  1994cited by this paper
• [Clinical assessment of physical dependence potential of dihydroetorphine hydrochloride (DHE)].

  1994cited by this paper
• Antagonists at excitatory opioid receptors on sensory neurons in culture increase potency and specificity of opiate analgesics and attenuate development of tolerance/dependence.

  1994cited by this paper
• Diagnostic and Statistical Manual of Mental Disorders, 4th Ed.

  1994cited by this paper
• Antinociceptive effect of dihydroetorphine and its tolerance/dependence liability in mice.

  1993cited by this paper
• Substance Abuse: A Comprehensive Textbook (2nd ed.)

  1993cited by this paper
• After chronic opioid exposure sensory neurons become supersensitive to the excitatory effects of opioid agonists and antagonists as occurs after acute elevation of GM1 ganglioside.

  1992cited by this paper
• After GM1 ganglioside treatment of sensory neurons naloxone paradoxically prolongs the action potential but still antagonizes opioid inhibition.

  1992cited by this paper
• Chronic selective activation of excitatory opioid receptor functions in sensory neurons results in opioid 'dependence' without tolerance.

  1992cited by this paper
• Involvement of supraspinal epsilon and mu opioid receptors in inhibition of the tail-flick response induced by etorphine in the mouse.

  1992cited by this paper
• Dependence studies on new compounds in the rhesus monkey, rat and mouse (1989).

  1989cited by this paper
• Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.

  1987cited by this paper
• pA 2 Analysis I: Schild Plot

  1987cited by this paper
• In vivo opiate receptor binding of oripavines to mu, delta and kappa sites in rat brain as determined by an ex vivo labeling method.

  1985cited by this paper
• Unidirectional non-cross-tolerance (UNCT) in rats and an apparent dissociation between narcotic tolerance and physical dependence.

  1985cited by this paper
• In vivo opiate receptor binding of oripavines to μ, σ and κ sites in rat brain as determined by an ex vivo labeling method

  1985cited by this paper
• [3H]Etorphine receptor binding in vivo. Small fractional occupancy elicits analgesia.

  1982cited by this paper
• Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.

  1982cited by this paper
• [3H]-etorphine and [3H]-diprenorphine receptor binding in vitro and in vivo: differential effect of Na+ and guanylyl imidodiphosphate.

  1982cited by this paper
• The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties

  1982cited by this paper
• Characterization of opioid receptors in nervous tissue

  1980cited by this paper
• Possible role of distinct morphine and enkephalin receptors in mediating actins of benzomorphan drugs (putative kappa and sigma agonists).

  1980cited by this paper
• Caffeine elicited withdrawal signs in morphine-dependent rhesus monkeys.

  1978cited by this paper
• The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.

  1977cited by this paper
• Etorphine in man. I. Subjective effects and suppression of morphine abstinence

  1975cited by this paper
• ANTINOCICEPTIVE ACTIVITY OF THE NARCOTIC ANTAGONIST ANALGESICS AND ANTAGONISTIC ACTIVTY OF NARCOTIC ANALGESICS IN RODENTS

  1971cited by this paper
• The effect of various neurohumoral modulators on the activity of morphine and the narcotic antagonists in the tail-flick and phenylquinone tests.

  1970cited by this paper
• Actions of etorphine hydrochloride, (M99): a potent morphine-like agent.

  1967cited by this paper
• Novel analgesics and molecular rearrangements in the morphine-thebaine group. 3. Alcohols of the 6,14-endo-ethenotetrahydrooripavine series and derived analogs of N-allylnormorphine and -norcodeine.

  1967cited by this paper
• Inhibition of writhing by narcotic antagonists.

  1966cited by this paper
• Synthetic analgesics. II. Dithienylbutenyl- and dithienylbutylamines.

  1953cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper
• A METHOD FOR DETERMINING LOSS OF PAIN SENSATION

  1941cited by this paper

• New cannabidiol structure-related terpene N-acyl-hydrazones with potent antinociceptive and anti-inflammatory activity.

  2025cites this paper
• New opioid receptor antagonist: Naltrexone‐14‐O‐sulfate synthesis and pharmacology

  2017influential citation
• Quinoline Alkaloids Isolated from Choisya Aztec-Pearl and Their Contribution to the Overall Antinociceptive Activity of This Plant

  2016cites this paper
• Antinociceptive effect and mechanism of action of isatin, N-methyl isatin and oxopropyl isatin in mice.

  2016cites this paper
• Central Antinociceptive and Mechanism of Action of Pereskia bleo Kunth Leaves Crude Extract, Fractions, and Isolated Compounds

  2015cites this paper
• Effect-site concentration and plasma concentration of remifentanil during TCI are not the same.

  2015cites this paper
• Exploring pharmacological activities and signaling of morphinans substituted in position 6 as potent agonists interacting with the μ opioid receptor

  2014cites this paper
• Analgesic activity of Eugenia jambolana leave constituent: A dikaempferol rhamnopyranoside from ethyl acetate soluble fraction

  2014cites this paper
• Antinociceptive esters of N-methylanthranilic acid: Mechanism of action in heat-mediated pain.

  2014cites this paper
• The discriminative stimulus effects of mecamylamine in nicotine-treated and untreated rhesus monkeys

  2014cites this paper
• Ethnopharmacological studies of Lippia origanoides

  2014cites this paper
• The µ opioid receptor and ligands acting at the µ opioid receptor, as therapeutics and potential therapeutics.

  2014cites this paper
• Lack of regulatory changes of µ-opioid receptors by 14-methoxymetopon treatment in rat brain. Further evidence for functional selectivity.

  2014cites this paper
• Convolutamydine A and synthetic analogues have antinociceptive properties in mice.

  2013cites this paper
• Evaluation of In Vitro Antioxidant and In Vivo Analgesic Potential of Terminalia paniculata Aqueous Bark Extract

  2013cites this paper
• Orvinols with Mixed Kappa/Mu Opioid Receptor Agonist Activity

  2013cites this paper
• Pharmacological mechanisms underlying the antinociceptive and tolerance effects of the 6,14-bridged oripavine compound 030418

  2011cites this paper
• Characterisation of the anti-inflammatory and antinociceptive activities of the Hyptis pectinata (L.) Poit essential oil.

  2011cites this paper
• Article 14.indd

  2011cites this paper
• Mixed Kappa/Mu Opioid Receptor Agonists: The 6 β Naltrexamines

  2011cites this paper
• Phytochemical profile and analgesic evaluation of Vitex cymosa leaf extracts

  2011cites this paper
• Different drug cocktails in the immobilization of the White Rhinoceros (Ceratotherium simum simum)

  2010cites this paper
• No hyperalgesia following opioid withdrawal after the oripavine derivative etorphine compared to remifentanil and sufentanil

  2010cites this paper
• Antinociceptive activity of fractions from Couroupita guianensis Aubl. leaves.

  2010cites this paper
• Characterization of the antinociceptive and anti-inflammatory activities of fractions obtained from Copaifera multijuga Hayne.

  2010cites this paper
• Mixed kappa/mu opioid receptor agonists: the 6 beta-naltrexamines.

  2009cites this paper
• Antinociceptive activity of Amazonian Copaiba oils.

  2007cites this paper
• Cinnamoyl derivatives of 7alpha-aminomethyl-6,14-endo-ethanotetrahydrothebaine and 7alpha-aminomethyl-6,14-endo-ethanotetrahydrooripavine and related opioid ligands.

  2007cites this paper
• Opioid agonist efficacy predicts the magnitude of tolerance and the regulation of mu-opioid receptors and dynamin-2.

  2007cites this paper
• Cinnamoyl Derivatives of 7α-Aminomethyl-6,14-endoethanotetrahydrothebaine and 7α-Aminomethyl-6,14-endoethanotetrahydrooripavine and Related Opioid Ligands

  2007cites this paper
• Pharmacological studies with a nonpeptidic, delta-opioid (-)-(1R,5R,9R)-5,9-dimethyl-2'-hydroxy-2-(6-hydroxyhexyl)-6,7-benzomorphan hydrochloride ((-)-NIH 11082).

  2007cites this paper
• Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats

  2006cites this paper
• Structural determinants of opioid activity in derivatives of 14-aminomorphinones: effect of substitution in the aromatic ring of cinnamoylaminomorphinones and codeinones.

  2006cites this paper
• Antinociceptive action of (+/-)-cis-(6-ethyl-tetrahydropyran-2-yl)-formic acid in mice.

  2006cites this paper
• Dihydroetorphine: a potent analgesic: pharmacology, toxicology, pharmacokinetics, and clinical effects.

  2006cites this paper
• Peripherally Mediated Antinociception of the (cid:1) -Opioid Receptor Agonist 2-[(4,5 (cid:2) -Epoxy-3-hydroxy-14 (cid:3) -methoxy-17-methylmorphinan-6 (cid:3) -yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation

  2006cites this paper
• CHAPTER 4 – Opioids

  2006cites this paper
• Peripherally Mediated Antinociception of the (cid:1) -Opioid Receptor Agonist 2-[(4,5 (cid:2) -Epoxy-3-hydroxy-14 (cid:3) -methoxy-17-methylmorphinan-6 (cid:3) -yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation

  2006cites this paper
• Peripherally Mediated Antinociception of the μ-Opioid Receptor Agonist 2-[(4,5α-Epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic Acid (HS-731) after Subcutaneous and Oral Administration in Rats with Carrageenan-Induced Hindpaw Inflammation

  2006cites this paper
• Peripheral versus Central Antinociceptive Actions of 6-Amino Acid-Substituted Derivatives of 14-O-Methyloxymorphone in Acute and Inflammatory Pain in the Rat

  2005cites this paper
• Peripherally mediated antinociception of the µ-opioid receptor agonist HS-731 after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation

  2005cites this paper
• Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.

  2005cites this paper
• Basal opioid receptor activity, neutral antagonists, and therapeutic opportunities.

  2005cites this paper
• BU74, a complex oripavine derivative with potent kappa opioid receptor agonism and delayed opioid antagonism.

  2005cites this paper
• Pharmacological properties of JDTic: a novel kappa-opioid receptor antagonist.

  2004cites this paper
• Characterization of the complex morphinan derivative BU72 as a high efficacy, long-lasting mu-opioid receptor agonist.

  2004cites this paper
• Discriminative stimulus, reinforcing, physical dependence, and antinociceptive effects of oxycodone in mice, rats, and rhesus monkeys.

  2004cites this paper
• Pharmacological properties of JDTic: a novel κ-opioid receptor antagonist

  2004cites this paper
• 14-Phenylpropyloxymorphinan-6-ones with Unanticipated Agonist Properties: Extending the Scope of Common Structure-Activity Relationships

  2003cites this paper
• Discriminative stimulus and antinociceptive effects of dihydroetorphine in rhesus monkeys

  2003influential citation
• Opioid ligands having delayed long-term antagonist activity: potential pharmacotherapies for opioid abuse.

  2003cites this paper
• Synthesis and biological evaluation of 14-alkoxymorphinans. 18. N-substituted 14-phenylpropyloxymorphinan-6-ones with unanticipated agonist properties: extending the scope of common structure-activity relationships.

  2003cites this paper
• Sex differences in opioid-induced enhancement of contact hypersensitivity.

  2003cites this paper
• Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.

  2003cites this paper
• Biochemical characterisation of newly developed β-etorphine and β-dihydroetorphine derivatives

  2002cites this paper
• Biochemical characterisation of newly developed beta-etorphine and beta-dihydroetorphine derivatives.

  2002cites this paper
• Pharmacokinetic and pharmacodynamic evaluations of a potent analgesic, dihydroetorphine, in hairless rat.

  2001cites this paper
• A protective effect against undesirable increase of dihydroetorphine permeation through damaged skin by using pressure-sensitive adhesive tape with an ethylene-vinyl acetate co-polymer membrane.

  2001cites this paper
• Protein kinases modulate the cellular adaptations associated with opioid tolerance and dependence.

  2001cites this paper
• Synthesis and in vitro and in vivo activity of (-)-(1R,5R,9R)- and (+)-(1S,5S,9S)-N-alkenyl-, -N-alkynyl-, and -N-cyanoalkyl-5, 9-dimethyl-2'-hydroxy-6,7-benzomorphan homologues.

  2000cites this paper
• Dihydroetorphine: physical dependence and stereotypy after continuous infusion in the rat.

  2000cites this paper
• Comparison of physical dependence of ohmefentanyl stereoisomers in mice.

  2000cites this paper
• In vitro and in vivo characterisation of buprenorphine and other long-lasting opioids

  1999cites this paper
• Chemistry of opium alkaloids. Part 44: synthesis and opioid receptor binding profile of substituted ethenoisomorphinans and ethenomorphinans.

  1999cites this paper
• Anti-allodynic actions of intravenous opioids in the nerve injured rat: potential utility of heroin and dihydroetorphine against neuropathic pain.

  1998cites this paper
• Modulation of opioid analgesia, tolerance and dependence by Gs-coupled, GM1 ganglioside-regulated opioid receptor functions.

  1998cites this paper
• Endogenous opiates: 1997.

  1998cites this paper
• 14-Phenylpropoxymetopon : An Extremely Powerful Analgesic

  year unknowncites this paper
• N-Substituted 14-Phenylpropyloxymorphinan-6-ones with Unanticipated Agonist Properties : Extending the Scope of Common Structure-Activity Relationships

  year unknowncites this paper